These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18196347)

  • 1. FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma.
    Kuo PH; McClennan BL; Carlson K; Wilson LD; Edelson RL; Heald PW; Girardi M
    Mol Imaging Biol; 2008; 10(2):74-81. PubMed ID: 18196347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R; Xiu Y; Zhuang HM; Alavi A
    Br J Dermatol; 2006 Aug; 155(2):357-63. PubMed ID: 16882175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial.
    Kuo PH; Carlson KR; Christensen I; Girardi M; Heald PW
    Mol Imaging Biol; 2008; 10(6):306-14. PubMed ID: 18665425
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
    Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
    Liu C; Zhang Y; Zhang Y; Wang M; Liu R; Liu X; Hu S
    Nucl Med Commun; 2016 May; 37(5):446-52. PubMed ID: 26657218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Before and after treatment 18F-FDG PET/CT images in a patient with cutaneous T-cell lymphoma.
    Kim JS; Jeong YJ; Sohn MH; Lim ST; Kim DW; Jeong HJ; Kwak JY; Yim CY
    Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1995. PubMed ID: 20658231
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary discussion on the value of (18)F-FDG PET/CT in the diagnosis and early staging of non-mycosis fungoides/Sézary's syndrome cutaneous malignant lymphomas.
    Dan S; Qiang G; Shu-Xia W; Chang-Hong L
    Eur J Radiol; 2015 Jul; 84(7):1293-8. PubMed ID: 25982461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
    Iagaru A; Quon A; McDougall IR; Gambhir SS
    Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.
    Vasanawala MS; Wang Y; Quon A; Gambhir SS
    Clin Nucl Med; 2006 Sep; 31(9):534-7. PubMed ID: 16921276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]-fluoro-D-glucose (18FDG) in a patient with cutaneous T-cell lymphoma.
    Mahmood S; Martínez de Llano SR
    Rev Esp Med Nucl; 2007; 26(5):306. PubMed ID: 17910841
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
    Qiu L; Tu G; Li J; Chen Y
    Nucl Med Commun; 2017 Feb; 38(2):106-116. PubMed ID: 27792043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous T-cell lymphoma: value of CT in staging and determining prognosis.
    Miketic LM; Chambers TP; Lembersky BC
    AJR Am J Roentgenol; 1993 May; 160(5):1129-32. PubMed ID: 8470594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET/CT in the evaluation of anal carcinoma.
    Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.
    Tsai EY; Taur A; Espinosa L; Quon A; Johnson D; Dick S; Chow S; Advani R; Warnke R; Kohler S; Hoppe RT; Kim YH
    Arch Dermatol; 2006 May; 142(5):577-84. PubMed ID: 16702495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.
    Reinhardt MJ; Joe AY; Jaeger U; Huber A; Matthies A; Bucerius J; Roedel R; Strunk H; Bieber T; Biersack HJ; Tüting T
    J Clin Oncol; 2006 Mar; 24(7):1178-87. PubMed ID: 16505438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
    Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
    J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.